Literature DB >> 19772295

Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold.

Panumart Thongyoo1, Camille Bonomelli, Robin J Leatherbarrow, Edward W Tate.   

Abstract

MCoTI-II is a member of a class of microproteins known as cyclotides that possess a macrolactam-cystine knot scaffold imparting exceptional physiological stability and structural rigidity. Modification of residues in the active loop and engineered truncations have resulted in MCoTI-II analogues that possess potent activity against two therapeutically significant serine proteases: beta-tryptase and human leukocyte elastase. These results suggest that MCoTI-II is a versatile scaffold for the development of protease inhibitors against targets in inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19772295     DOI: 10.1021/jm901233u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  34 in total

1.  Isolation, amino acid sequence and biological activities of novel long-chain polyamine-associated peptide toxins from the sponge Axinyssa aculeata.

Authors:  Satoko Matsunaga; Mitsuru Jimbo; Martin B Gill; L Leanne Lash-Van Wyhe; Michio Murata; Ken'ichi Nonomura; Geoffrey T Swanson; Ryuichi Sakai
Journal:  Chembiochem       Date:  2011-08-09       Impact factor: 3.164

2.  Structural insights into the role of the cyclic backbone in a squash trypsin inhibitor.

Authors:  Norelle L Daly; Louise Thorstholm; Kathryn P Greenwood; Gordon J King; K Johan Rosengren; Begoña Heras; Jennifer L Martin; David J Craik
Journal:  J Biol Chem       Date:  2013-10-29       Impact factor: 5.157

Review 3.  Protein scaffold-based molecular probes for cancer molecular imaging.

Authors:  Zheng Miao; Jelena Levi; Zhen Cheng
Journal:  Amino Acids       Date:  2010-02-21       Impact factor: 3.520

Review 4.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

5.  Cyclic peptides arising by evolutionary parallelism via asparaginyl-endopeptidase-mediated biosynthesis.

Authors:  Joshua S Mylne; Lai Yue Chan; Aurelie H Chanson; Norelle L Daly; Hanno Schaefer; Timothy L Bailey; Philip Nguyencong; Laura Cascales; David J Craik
Journal:  Plant Cell       Date:  2012-07-20       Impact factor: 11.277

Review 6.  Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery.

Authors:  Andrew Gould; Yanbin Ji; Teshome L Aboye; Julio A Camarero
Journal:  Curr Pharm Des       Date:  2011-12       Impact factor: 3.116

Review 7.  Neutrophil elastase inhibitors.

Authors:  William C Groutas; Dengfeng Dou; Kevin R Alliston
Journal:  Expert Opin Ther Pat       Date:  2011-01-16       Impact factor: 6.674

Review 8.  Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.

Authors:  Julio A Camarero
Journal:  Bioorg Med Chem Lett       Date:  2017-10-21       Impact factor: 2.823

9.  Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.

Authors:  Teshome L Aboye; Helen Ha; Subhabrata Majumder; Frauke Christ; Zeger Debyser; Alexander Shekhtman; Nouri Neamati; Julio A Camarero
Journal:  J Med Chem       Date:  2012-11-27       Impact factor: 7.446

10.  Semienzymatic cyclization of disulfide-rich peptides using Sortase A.

Authors:  Xinying Jia; Soohyun Kwon; Ching-I Anderson Wang; Yen-Hua Huang; Lai Y Chan; Chia Chia Tan; K Johan Rosengren; Jason P Mulvenna; Christina I Schroeder; David J Craik
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.